|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02181 MABPHARM-B
Nominal 
0.365 +0.030 (+8.955%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 615,232 | -3.312% | 636,306 | 483,673 | 438,408 | 255,049 |
| Land & other Lease Assets | 71,304 | 5.313% | 67,707 | 77,374 | 74,209 | 77,346 |
| Intangible Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 6,231 | -49.701% | 12,388 | 91,085 | 81,294 | 108,943 |
| 692,767 | -3.299% | 716,401 | 652,132 | 593,911 | 441,338 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 102,037 | 1.230% | 100,797 | 53,211 | 33,427 | 22,224 | |
| Trade Receivables | 19,423 | 103.766% | 9,532 | 793 | 0 | 0 | |
| Cash & Bank Balances | 173,345 | 416.400% | 33,568 | 81,556 | 484,846 | 588,720 | |
| Other Current Assets | 47,401 | -17.164% | 57,223 | 112,210 | 50,853 | 344,195 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 342,206 | 70.150% | 201,120 | 247,770 | 569,126 | 955,139 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 10,012 | -39.636% | 16,586 | 12,860 | 4,466 | 4,401 | ||
| S-T Debt & Leases | 125,258 | 842.427% | 13,291 | 9,283 | 8,532 | 70,500 | ||
| Other Current Liabilities | 180,921 | 14.128% | 158,524 | 212,861 | 189,629 | 195,433 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 316,191 | 67.829% | 188,401 | 235,004 | 202,627 | 270,334 | |||
| Net Current Assets | 26,015 | 104.537% | 12,719 | 12,766 | 366,499 | 684,805 | ||
| Total Assets Less Current Liabilities | 718,782 | -1.418% | 729,120 | 664,898 | 960,410 | 1,126,143 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 134,815 | 19.257% | 113,046 | 36,407 | 31,816 | 35,123 | |||
| Other Non-current Liabilities | 378,910 | 76.131% | 215,130 | 26,510 | 47,109 | 37,309 | |||
| 513,725 | 56.539% | 328,176 | 62,917 | 78,925 | 72,432 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 2,804 | 0.000% | 2,804 | 2,804 | 2,804 | 2,804 | ||||
| Reserves | 202,253 | -49.201% | 398,140 | 599,177 | 878,681 | 1,050,907 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 205,057 | -48.856% | 400,944 | 601,981 | 881,485 | 1,053,711 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 205,057 | -48.856% | 400,944 | 601,981 | 881,485 | 1,053,711 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 3,978 | -80.838% | 20,760 | 138,649 | 138,014 | 182,332 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -97,569,000 |
| %Change | -2.430% |
| EPS / (LPS) | RMB -0.020 |
| NBV Per Share (¥) | RMB 0.028 |